Kiniksa Pharmaceuticals International Plc. PEG Ratio

Kiniksa Pharmaceuticals International Plc. (KNSA) currently reports a PEG ratio of 169.37. That is above the Healthcare sector average of 3.22. Use the charts on this page to explore Kiniksa Pharmaceuticals International Plc.'s PEG ratio history and peer comparisons.

Kiniksa Pharmaceuticals International Plc.'s PEG ratio of 169.37 is higher than the Healthcare sector average of 3.22. That is roughly 5155.8% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Kiniksa Pharmaceuticals International Plc.'s market price to a fundamental measure such as earnings, sales, or book value. At 169.37, KNSA can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of 169.37, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 3.22. From there, open related valuation or income-statement pages for Kiniksa Pharmaceuticals International Plc., and consider following KNSA for alerts when major investors trade the stock.

Kiniksa Pharmaceuticals International Plc. is classified in the Healthcare sector. On PEG ratio, it currently shows 169.37 versus a sector average near 3.22. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KNSA with unrelated industries.